- $8.94m
- -$4.16m
- $3.03m
Brief: Neurometrix - Filed A Prospectus Supplement To Register Offer And Sale Of $1.1 Mln Of Stock
Brief: NeuroMetrix Reports Q1 2020 Financial Results
NeuroMetrix: Jumps after nerve stimulation device chosen for NIH-funded study
Brief: Neurometrix Says Quell Technology Selected For Use In Clinical Trial Of TENS For Fibromyalgia
U.S. STOCKS ON THE MOVE-Wall St banks, U.S. airlines, casinos, Tesla, J&J, Apple, Roku
Brief: Neurometrix Says Reached Settlement With Federal Trade Commission Of Previously Reported Investigation
Brief: Neurometrix Inc Says May Offer And Sell Shares Of Common Stock Having Aggregate Offering Price Of Up To $2.2 Million From Time To Time
U.S. STOCKS ON THE MOVE-Vaccine makers, casino operators, toymakers, energy stocks
NeuroMetrix: Set for worst day in over 10 yrs on disappointing Q4 revenue
U.S. STOCKS ON THE MOVE-AbbVie, Walt Disney, Airlines, Casino Operators
Brief: Neurometrix Q4 Total Revenues Were $1.7 Million
U.S. STOCKS ON THE MOVE-Nio, Axsome Therapeutics, Maxar Technologies, GameStop
Brief: NeuroMetrix Reports Q3 2019 Financial Results
U.S. STOCKS ON THE MOVE-Whiting Petroleum, Delta Air Lines, Aecom
NeuroMetrix hits record low after swinging to Q2 loss
Brief: Neurometrix Q2 Revenue Fell 37% To $2.4 Million
Brief: Neurometrix Says Has Implemented A Reduction In Force Affecting 11 Employees
Brief: Neurometrix Announces Issuance Of New U.S. Patent For Quell Wearable Technology
Brief: Neurometrix Reports Q1 Revenue of $3.1 Million, Down 37 Pct